Moderna CEO Stephane Bancel & Regeneron CEO Leonard Schleifer on a Coronavirus vaccine
Fintech can help in the response to COVID-19. But where should policymakers start?
UCF receives NSF RAPID Award to develop cough drops to help control COVID-19
Training in the Age of Social Distancing. Can AR/VR/MR Provide the Answer?
Empire State Realty Trust Poised To Bear The Full Brunt Of This Storm
New Information Trickling In Slowly
If you open it, they still won’t come: restaurant edition
Consumer Price Index Plunges 0.8 Percent, Core Falls 0.4 Percent
Researchers testing northern Arizona wastewater for early warning of COVID-19 outbreaks
Emerging from the Great Lockdown in Asia and Europe
3 "Strong Buy" Dividend Stocks That Look Great After Earnings Beat
April deflation follows a typical recessionary pattern
With money flowing, Pliant Therapeutics heads to public well
2 Cruise Line Stocks to Bet on After the Coronavirus Crisis (And 1 to Avoid)
Peloton Shares Increase on 1 Million Fitness Subscriber Milestone
Department of Defense awards $10M to Sanford Burnham Prebys for broad-spectrum antivirals
DAX attacks 11,000 on COVID-19 treatment hopes - sustainable?
Who wins when banks distribute government loans? Funding small businesses in times of crisis
Logitech Leaps Almost 6% As Stay-At-Home Orders Boost Quarterly Sales
Zynga Inc. (ZNGA) Earnings Show EPS Loss of 11 Cents
The Three Clean Air Stocks Thriving During the Pandemic
Ryanair Plans to Resume 40% of Flights in July
Tesla’s Elon Musk to Reopen California Plant Despite Coronavirus Restrictions
Operational lessons for COVID-19 (coronavirus): What can we learn from past outbreaks?
Free trade now: A case for tariff reductions and non-tariff measures simplifications to fight COVID-19 (coronavirus)
[PULSE] A new lending environment will bring new mortgage fraud risks
Tesla: Moving Fremont a Risky Move, Says Analyst
Costly car loans may stall the COVID-19 economic recovery
As Economy Reopens Investors Need Actionable News
Inovio’s COVID-19 Vaccine Candidate Has the Edge Over Moderna’s, Says 5-Star Analyst